Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by fluctuating muscle weakness. Double‐filtration plasmapheresis (DFPP) and efgartigimod are commonly used therapeutic strategies for patients with generalized MG (gMG). This single‐center retrospective study aimed to evaluate and compare the...